Differential modulation of chemosensitivity to alkylating agents and platinum compounds by DNA repair modulators in human lung cancer cell lines

Journal of Cancer Research and Clinical Oncology

Volumn 126, Issue 4, 2000, Pages 198-204

  Heim, M M ^a   Eberhardt, W ^a   Seeber, S ^a   Muller M R ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

DNA repair; Drug resistance; Resistance modifier

Indexed keywords

6 O BENZYLGUANINE; ALKYLATING AGENT; APHIDICOLIN; CARBOPLATIN; CARMUSTINE; CHLORAMBUCIL; CISPLATIN; FLUDARABINE; MAFOSFAMIDE; METHOXAMINE; PENTOXIFYLLINE; PLATINUM DERIVATIVE;

ARTICLE; CANCER RESISTANCE; CHEMOSENSITIVITY; COLORIMETRY; CYTOTOXICITY; DNA REPAIR; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL;

EID: 0034032136     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050033     Document Type: Article

References (28)

1. Aebi S, Kurdi-Haidar B, Gordon R, Cenni B, Zheng H, Fink D, Christen RD, Boland CR, Koi M, Fishel R, Howell SB (1996) Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res 56: 3087-3090
2. Beermann B, Ings R, Mansby J, Chamberlain J, McDonald A (1985) Kinetics of intravenous and oral pentoxifylline in healthy subjects. Clin Pharmacol Ther 37: 25-28
3. Bernges F, Zeller WJ (1996) Combination effects of poly(ADP-ribose) polymerase inhibitors and DNA-damaging agents in ovarian tumor cell lines - with special reference to cisplatin. J Cancer Res Clin Oncol 122: 665-670
4. Buschfort C, Müller MR, Seeber S, Rajewsky MF, Thomale J (1997) DNA excision repair profiles of normal and leukemic human lymphocytes: functional analysis at the single-cell level. Cancer Res 57: 651-658
5. Chaney SG, Sancar A (1996) DNA repair: enzymatic mechanisms and relevance to drug response. J Natl Cancer Inst 88: 1346-1360
6. Dobmeyer DJ, Stine RA, Leier CV, Greenberg R, Schaal SF (1983) The arrhythmogenic effects of caffeine in human beings. N Engl J Med 308: 814-816
7. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc Natl Acad Sci USA 87: 5368-5372
8. Domon M, Rauth AM (1969) Effects of caffeine on ultraviolet-irradiated mouse L cells. Radiat Res 39: 207-221
9. Fingert HJ, Chang JD, Pardee AB (1986) Cytotoxic, cell cycle and chromosomal effects of methylxanthines in human tumor cells treated with alkylating agents. Cancer Res 46: 2463-2467
10. 6-benzylguanine for patients undergoing surgery for malignant glioma. J Clin Oncol 16: 3570-3575
11. 6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis 7: 745-749
12. Ikegami S, Taguchi T, Ohashi M, Oguro M, Nagano H, Mano Y (1978) Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-α. Nature 275: 458-460
13. Lai GM, Ozols RF, Smyth JF, Young RC, Hamilton TC (1988) Enhanced repair as a mechanism of resistance to cis-diamminedichloroplatinum (II). Biochem Pharmacol 37: 4597-1600
14. Li L, Liu X, Glassman AB, Keating MJ, Stros M, Plunkett W, Yang LY (1997) Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro. Cancer Res 57: 1487-1494
15. Müller MR, Wright KA, Twentyman PR (1991) Differential properties of cisplatin and tetraplatin with respect to cytotoxicity and perturbation of cellular glutathione levels. Cancer Chemother Pharmacol 28: 273-276
16. 6-benzylguanine and ethacrynic acid in haematological malignancies. Anticancer Res 13: 2155-2160
17. Müller MR, Lennartz K, Nowrousian MR, Dux R, Tsuruo T, Rajewsky MF, Seeber S (1994) Improved flow-cytometric detection of low P-glycoprotein expression in leukaemic blasts by histogram subtraction analysis. Cytometry 15: 64-72
18. Petru E, Boike G, Sevin BU (1990) Potentiation of cisplatin cytotoxicity by methylxanthines in vitro. J Cancer Res Clin Oncol 116: 431-433
19. Rosa S, Fortini P, Karran P, Bignami M, Dogliotti E (1991) Processing in vitro of an abasic site reacted with methoxyamine: a new assay for the detection of abasic sites formed in vivo. Nucleic Acids Res 19: 5569-5574
20. Samson LD (1992) The repair of DNA alkylation damage by methyltransferases and glycosylases. Essays Biochem 27: 69-78
21. Sancar A (1995) DNA repair in humans. Annu Rev Genet 29: 69-105
22. Sargent JM, Elgie AW, Williamson CJ, Taylor CG (1996) Aphidicolin markedly increases the platinum sensitivity of cells from primary ovarian tumours. Br J Cancer 74: 1730-1733
23. Selby CP, Sancar A (1990) Molecular mechanisms of DNA repair inhibition by caffeine. Proc Natl Acad Sci USA 87: 3522-3525
24. Selby CP, Sancar A (1991) Noncovalent drug-DNA binding interactions that inhibit and stimulate (A)BC excinuclease. Biochemistry 30: 3841-3849
25. Sessa C, Zucchetti M, Davoli E, Califano R, Cavalli F, Frustaci S, Gumbrell L, Sulkes A, Winograd B, D'Incalci M (1991) Phase I and clinical pharmacological evaluation of aphidicolin glycinate. J Natl Cancer Inst 83: 1160-1164
26. Stewart DJ, Evans WK, Logan D (1994) Addition of pentoxifylline plus nifedipine to chemotherapy in patients with cisplatin-resistant cancers of the lung and other sites. Am J Clin Oncol 17: 313-316
27. Twentyman PR, Wright KA, Rhodes T (1991) Radiation response of human lung cancer cells with inherent and acquired resistance to cisplatin. Int J Radiat Oncol Biol Phys 20: 217-220
28. Yang LY, Li L, Keating MJ, Plunkett W (1995) Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair. Mol Pharmacol 47: 1072-1079